BLAIR WILLIAM & CO/IL - ALBIREO PHARMA INC ownership

ALBIREO PHARMA INC's ticker is ALBO and the CUSIP is 01345P106. A total of 105 filers reported holding ALBIREO PHARMA INC in Q2 2022. The put-call ratio across all filers is 0.28 and the average weighting 0.2%.

Quarter-by-quarter ownership
BLAIR WILLIAM & CO/IL ownership history of ALBIREO PHARMA INC
ValueSharesWeighting
Q4 2022$334,004
+12.1%
15,456
+0.5%
0.00%0.0%
Q3 2022$298,000
-60.3%
15,381
-59.3%
0.00%
-66.7%
Q2 2022$751,000
-54.9%
37,836
-32.3%
0.00%
-50.0%
Q1 2022$1,667,000
-1.7%
55,871
-23.3%
0.01%
+20.0%
Q4 2021$1,696,000
-35.0%
72,838
-12.9%
0.01%
-44.4%
Q3 2021$2,609,000
+22.5%
83,613
+38.1%
0.01%
+28.6%
Q2 2021$2,130,000
+1.7%
60,542
+1.9%
0.01%
-12.5%
Q1 2021$2,095,000
+3.7%
59,425
+10.3%
0.01%
+14.3%
Q4 2020$2,021,000
+26.6%
53,873
+12.7%
0.01%0.0%
Q3 2020$1,596,000
+63.5%
47,814
+29.8%
0.01%
+40.0%
Q2 2020$976,000
+47.4%
36,844
-8.9%
0.01%
+25.0%
Q1 2020$662,000
-33.4%
40,426
+3.4%
0.00%
-20.0%
Q4 2019$994,000
+6.0%
39,088
-16.7%
0.01%0.0%
Q3 2019$938,000
-39.5%
46,915
-2.5%
0.01%
-44.4%
Q2 2019$1,551,000
+65.0%
48,110
+64.8%
0.01%
+50.0%
Q1 2019$940,000
+39.3%
29,199
+6.1%
0.01%
+20.0%
Q4 2018$675,00027,5220.01%
Other shareholders
ALBIREO PHARMA INC shareholders Q2 2022
NameSharesValueWeighting ↓
Prosight Management, LP 270,146$6,627,0003.42%
Perceptive Advisors 1,704,330$39,506,0001.50%
Birchview Capital, LP 38,000$932,0000.88%
SECTORAL ASSET MANAGEMENT INC 229,978$5,641,0000.77%
BVF INC/IL 200,500$4,918,0000.64%
Artal Group S.A. 500,000$12,265,0000.45%
PA Capital LLC 14,692$360,0000.38%
Chicago Capital, LLC 180,911$4,438,0000.36%
TPG Group Holdings (SBS) Advisors, Inc. 716,381$17,573,0000.28%
Fosun International Ltd 197,005$4,492,0000.27%
View complete list of ALBIREO PHARMA INC shareholders